‘I am not someone who gets skin cancer’: risk, time and malignant melanoma

References

• Alaszewski, A., 2010. Information about health risks. In: B. Heyman, M. Shaw, A. Alaszewski, and A.M. Titterton, eds. Risk, safety and clinical practice. Oxford: Oxford University Press, 123–136.
   Google Scholar
• Andersen, B.L., et al., 1995. Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. British journal of social psychology, 34, 33–52.
   PubMed Web of Science ®Google Scholar
• Andersen, R.S., et al., 2010. ‘Containment’ as an analytical framework for understanding patient delay: a qualitative study of cancer patients’ symptom interpretation processes. Social science and medicine, 71, 378–385.
   PubMed Web of Science ®Google Scholar
• Baade, P.D., et al., 2006. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Archives of dermatology, 142, 1422–1427.
   PubMed Web of Science ®Google Scholar
• Balch, C.M., et al., 2001. Prognostic factors analysis of 17,600 melanoma patients: validation of the American joint committee on cancer melanoma staging system. Journal of clinical oncology, 19 (16), 3622–3634.
   PubMed Web of Science ®Google Scholar
• Barnett, J. and Breakwell, G.M., 2003. The social amplification of risk and the hazard sequence: the October 1995 oral contraceptive pill scare. Health, risk & society, 5, 301–313.
   Web of Science ®Google Scholar
• Bataille, V. and de Vries, E., 2008. Melanoma – part 1: epidemiology, risk factors, and prevention. British medical journal, 337, 1287–1291.
   Google Scholar
• Berwick, M. and Wiggins, C., 2006. The current epidemiology of cutaneous malignant melanoma. Frontiers in bioscience, 11, 1244–1254.
   PubMed Web of Science ®Google Scholar
• Brochez, L., et al., 2001. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. Journal of the American academy of dermatology, 44, 976–986.
   Google Scholar
• Cancer Research, UK., 2013. Skin cancer incidence statistics [online]. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/skin/incidence/ [Accessed 9 September 2013].
   Google Scholar
• Chang, Y.M., et al., 2009. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. International journal of epidemiology, 38, 814–830.
   PubMed Web of Science ®Google Scholar
• Charmaz, K., 2006. Constructing grounded theory: a practical guide through qualitative analysis. London: Sage.
   Google Scholar
• Coory, M., et al., 2006. Trends for in situ and invasive melanoma in Queensland, Australia, 1982–2002. Cancer causes and control, 17, 21–27.
   PubMed Web of Science ®Google Scholar
• Diepgen, T.L. and Mahler, V., 2002. The epidemiology of skin cancer. British journal of dermatology, 146, 1–6.
   PubMed Web of Science ®Google Scholar
• Eagle, L., et al., 2010. National skin cancer campaigns. London: National Institute for Health and Clinical Excellence.
   Google Scholar
• Egan, K.M., 2009. Vitamin D and melanoma. Annals of epidemiology, 19, 455–461.
   PubMed Web of Science ®Google Scholar
• Erickson, C. and Driscoll, M., 2010. Melanoma epidemic: facts and controversies. Clinics in dermatology, 28, 281–286.
   PubMed Web of Science ®Google Scholar
• Faye, R.S., Helsing, P., and Langmark, F., 2000. [Diagnostic delay in malignant melanoma]. Tidsskrift for den Norske lægeforening: tidsskrift for praktisk medicin, ny række, 120, 1023–1125.
   Google Scholar
• Gandini, S., et al., 2005. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. European journal of cancer, 41, 45–60.
   PubMed Web of Science ®Google Scholar
• Gigerenzer, G., 2002. Reckoning with risk. London: Penguin Books.
   Google Scholar
• Goldenhersh, M.A. and Koslowsky, M., 2011. Increased melanoma after regular sunscreen use? Journal of clinical oncology, 29, e557–e558.
   PubMed Web of Science ®Google Scholar
• Green, A., et al., 2007. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. International journal of cancer, 120, 1116–1122.
   PubMed Web of Science ®Google Scholar
• Hajdarevic, S., et al., 2011. Malignant melanoma: gender patterns in care seeking for suspect marks. Journal of clinical nursing, 20, 2676–2684.
   PubMed Web of Science ®Google Scholar
• Hamidi, R., et al., 2010. Efficacy of skin self‐examination for the early detection of melanoma. International journal of dermatology, 49, 126–134.
   PubMed Web of Science ®Google Scholar
• Hartley, L.P., 1953. The go-between. Harmondsworth: Penguin Books.
   Google Scholar
• Heyman, B. and Titterton, M., 2010. Introduction. In B. Heyman, M. Shaw, A. Alaszewski, and A.M. Titterton, eds. Risk, safety and clinical practice: health care through the lens of risk. Oxford: Oxford University Press, 1–13.
   Google Scholar
• Hooker, C., et al., 2009. Writing the risk of cancer: cancer risk in public policy. Health, risk & society, 11, 541–560.
   Web of Science ®Google Scholar
• Kearney, J., 2013. Perceptions of non-accidental child deaths as preventable events: the impact of probability heuristics and biases on child protection work. Health, risk & society, 15, 51–66.
   Google Scholar
• Kuzel, A.J., 1992. Sampling in qualitative inquiry. In: B.F. Crabtree and W.L. Miller, eds. Doing qualitative research. Newbury Park, CA: Sage.
   Google Scholar
• Law, J., 1996. Organisation and semiotics: technology, agency and representation. In: R. Munro and J. Mauritsen, eds. Accountability, power and ethics. London: Chapman and Hall.
   Google Scholar
• Levell, N.J., et al., 2009. Melanoma epidemic: a midsummer night’s dream. British journal of dermatology, 161, 630–634.
   PubMed Web of Science ®Google Scholar
• MacKie, R.M., et al., 2007. Melanoma incidence and mortality in Scotland 1979–2003. British journal of cancer, 96, 1772–1777.
   Google Scholar
• Markovic, S.N., et al., 2007. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo clinic procedures, 82, 364–380.
   Google Scholar
• Marsden, J.R., et al., 2010. Revised UK guidelines for the management of cutaneous melanoma 2010. British journal of dermatology, 163, 238–256.
   PubMed Web of Science ®Google Scholar
• Mistry, M., et al., 2011. Cancer incidence in the United Kingdom: projections to the year 2030. British journal of cancer, 105, 1795–1803.
   PubMed Web of Science ®Google Scholar
• Moran, B., et al., 2011. Complete skin examination is essential in the assessment of dermatology patients: findings from 483 patients. British journal of dermatology, 165, 1124–1126.
   PubMed Web of Science ®Google Scholar
• Morton, C.A. and Mackie, R.M., 1998. Clinical accuracy of the diagnosis of cutaneous malignant melanoma. British journal of dermatology, 138, 283–287.
   PubMed Web of Science ®Google Scholar
• NICE, 2011. Skin cancer prevention: information, resources and environmental changes [online]. Available from: http://www.nice.org.uk/guidance/PH32 [Accessed 9 September 2013].
   Google Scholar
• Nkosana-Nyawata, I.D.S., 2009. Understanding delay: a grounded theory examination of the pre-diagnostic journey of individuals with malignant melanoma. Unpublished PhD Thesis.University of Bradford, Bradford.
   Google Scholar
• Nørgaard, C., et al., 2011. Are all melanomas dangerous? Acta dermato-venereologica, 91, 499–503.
   PubMed Web of Science ®Google Scholar
• Nyawata, I.D. and Topping, A.E., 2006. Symptom interpretation as a source of delay in malignant melanoma presentation – a literature review. Clinical effectiveness in nursing, 9, e68–e78.
   Google Scholar
• Pack, G.T. and Gallo, J.S., 1938. The culpability for delay in treatment of cancer. American journal of cancer, 33, 443–462.
   Google Scholar
• Pockney, P., et al., 2009. Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial. British journal of cancer, 100, 24–27.
   PubMed Web of Science ®Google Scholar
• Prestwich, R.J., et al., 2008. The immune system – is it relevant to cancer development, progression and treatment? Clinical oncology, 20, 101–112.
   PubMed Web of Science ®Google Scholar
• Richard, M.A., et al., 2000. Delays in Diagnosis and melanoma prognosis (1): the role of patients. Internal journal of cancer, 89, 271–279.
   PubMed Web of Science ®Google Scholar
• Robertson, A., 2000. Embodying risk, embodying political rationality: women's accounts of risks for breast cancer. Health, risk & society, 2, 219–235.
   Web of Science ®Google Scholar
• Scamell, M. and Alaszewski, A., 2012. Fateful moments and the categorisation of risk: midwifery practice and the ever-narrowing window of normality during childbirth. Health, risk & society, 14, 207–221.
   Web of Science ®Google Scholar
• Scott, S.E., et al., 2013. The model of pathways to treatment. Conceptualization and integration with existing theory British journal of social psychology, 18, 45–64.
   Google Scholar
• Strauss, A. and Corbin, J.M., 1990. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park, CA: Sage.
   Google Scholar
• Tejera‐Vaquerizo, A., et al., 2010. Growth rate as a prognostic factor in localized invasive cutaneous melanoma. Journal of the European academy of dermatology and venereology, 24, 147–154.
   PubMed Web of Science ®Google Scholar
• The Melanoma Task Force, 2012. Quality in melanoma care: a best practice pathway [online]. Available from: www.bapras.org.uk/downloaddoc.asp?id=856 [Accessed 4 September 2013].
   Google Scholar
• Timmermans, S. and Buchbinder, M., 2010. Patients-in-waiting: living between sickness and health in the genomics era. Journal of health and social behaviour, 51, 408–423.
   PubMed Web of Science ®Google Scholar
• Whiteman, D.C., et al., 2008. Changes in the incidence of cutaneous melanoma in the West of Scotland and Queensland, Australia: hope for health promotion? European journal of cancer prevention, 17, 243–250.
   PubMed Web of Science ®Google Scholar